Brain Tumor News!


Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 1401 to 1420 of 7,645
Previous 20           Next 20


11/15/17 Medicenna Presents Clinical Data From Previous Phase 1 and 2 Clinical Trials of MDNA55        

 Impressive results. 20% complete response rate form a single injection of this drug, and no serious side effects.  This is the type of treatment that should be approved immediately.



11/10/17 Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models        

 This is a new way to target brain tumors.  We are proud to say the Musella Foundation was one of the sponsors of the research.



11/07/17 Liquid Biopsy Spots Aggressive Pediatric Brainstem Cancer Earlier        

 This blood (and spinal fluid) test can help diagnose and  monitor the response to treatment for these devastating tumors.  There are drugs under development which target the marker mentioned, so this blood test might be able to be used to determine which patients get these new drugs, without the need for biopsies. Amazing stuff.  And we are proud to say we are one of the sponsors.  Your donations at work!



11/05/17 ONC201 Trial for Histone Mutant Glioma Begins at NYU        

 This mutation is a bad prognostic sign, but they have a 15 year survivor on this medication.  



11/05/17 Making medicine, not money: How one U of T researcher's startup is rethinking Big Pharma's business model        

 I love this model. Combine it with our proposal to speed up access to experimental drugs and we may have a cure much sooner than we thought!



11/01/17 U.S. experts set research agenda to meet 'Cancer Moonshot' goals        

 It is a good start, especially the part about tracking treatments after approval, but if they were serious about finding the cure  they would incorporate earlier approvals as outlined here. That would cut the time and costs by an order of magnitude. 



10/30/17 Health Beat: MDNA trial for glioblastoma        

 Video explains the trial.



10/28/17 Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment        

 This is a presentation about the Toca 511 / Toca FC  trial.   There are 6 long term survivors (4 GBM, 2 AA), all of whom had a complete response,  And once they achieve a complete response, NONE had a recurrence.  We never use the word "cured" when talking about a GBM, but having a clear scan for over 3 years makes us think it is possible a few of these patients may have been cured.  It is only a small  % at this time - 43% have some benefit from the treatment, and 20% have a significant response.  Hopefully it will only get better and this may lead to a major breakthrough.

The Musella Foundation was an early supporter of this research (and they acknowledge us on the presentation:)



10/26/17 Tocagen to Accelerate Toca 511 & Toca FC Development into Pivotal Phase 3 Trial        

 The Tocagen trial is open again, for patients with high grade glioma.  



10/25/17 Optune trials opens for adult patients with low grade gliomas and pediatric patients with high grade gliomas        

These are exciting trials. 

It is nice to see more research on other uses for the Optune device.  



10/24/17 Incidental findings abound on brain scans of the general pediatric population        

 Very scary - 1/4 of all children had a brain abnormality on MRI. Only 1/2 of 1% had something serious.   I am not sure what this means for the concept of routine screening for brain tumors.  The vast majority of abnormalities is nothing serious but might cause unnecessary surgery and worry.



10/18/17 Arsenic identified as a potential treatment for brain cancer        

 These researchers looked back at a failed trial and found that for a specific subtype of gbm, it actually doubles or triples average survival.  They are running a trial on that subtype now.



10/18/17 Diffusion Sprints on FDA Nod for Brain Cancer Treatment        

 This clinical trial should be considered by anyone with an inoperable gbm. Early results looked very good.



10/18/17 Clinical trial targets the most common form of brain cancer        

 This is an interesting video about the trial of MDNA55. This is a new approach to treatment and did well in earlier studies.  (Medicenna is a sponsor of the Musella Foundation)



10/12/17 Fake Blogs: Warnings About Medical Advice from Online ‘Experts’        

 This is the greatest benefit of our online support groups.  We have people who have been through everything, and have researched everything.  It is a place where you can boucne ideas off of others instead of just finding random medical advice on the internet.  It is impossible for someone who was recently diagnosed to understand the difference between real and fake news.  They so much want to find a cure that they may be easily mislead by unscrupulous people.  Actually, some of the people promoting these cures are good people who actually believe in it - because they do not have the background to understand how science works. An example:  a relative was fighting a gbm and went through ups and downs.  One down (after her 3rd course of radiation) was so bad we thought it was the end. She could only eat lemon ices. Had trouble chewing and swallowing anything else. And she had a miraculous recovery. In her mind, it was due to the lemon ices and she was telling people to eat lemon ices. In reality - the down was caused by damage and swelling from the radiation, which she recovered from.  It is all in the point of view.

The best online support group for brain tumor patients is the braintumor treatments group at https://virtualtrials.com/braintumor-treatments.cfm



10/11/17 Mustang CAR-T brain tumor trial gets funds to expand        

 This is one of the most promising treatments in the pipeline.



10/11/17 Immunomic Therapeutics Offers Travel Fund for Clinical Trial Patients        

 This is another of my favorite trials,  They now offer free travel to Florida for participants!



10/11/17 Areas of glioblastoma tumors correlate with separate subtypes of glioma stem cells        

 This is the type of research and thinking that can lead to major breakthroughs. Figuring out why treatments fail, and putting together intelligent combinations is the path to breakthroughs.  This research is in mice, hope they try it on people soon.



10/10/17 Medicenna Presents Clinical Data on Initial Experience from Ongoing Phase 2b Study of MDNA55        

 They did not say how the patients did, but they did report that they were able to deliver the drug to the correct place in a higher percentage of the time than in previous trials.  That was the big problem with previous trials involving convection enhanced delivery.  In the first such trial, the PRECISE trial, it was found that most or all of the patients did not get the drug to the correct place - which didn't give the drug a chance to work - so the trial failed. More recently the Tocagen trials have used CED and have vastly improved the ability to get the drug where it needs to go. Hopefully this is another step toward getting the drug to the correct place 100% of the time.

(Disclaimer: Medicenna is a sponsor of the Musella Foundation)



10/10/17 New resources for children affected by brain tumors in the family!        

 We partnered with the Pediatric Brain Tumor Foundation to distribute these animated films for any kids who either have a tumor or know someone with a tumor. Makes it easy to explain to kids what is going on.  



Displaying Stories 1401 to 1420 of 7645
Previous 20           Next 20